Skip to main content
. 2025 Aug 12;13:1606381. doi: 10.3389/fpubh.2025.1606381

Figure 2.

Flowchart illustrating a process for studying cognitive impairment risk in community pharmacy patients. Steps are: Ethical Committee approval and pharmacy agreement lead to enrollment. Data collection gathers socio-demographic and health information. Cognitive screening assesses functions using s-MoCA score. Risk factor identification uses CAIDE and s-MoCA scores. Medicine risk is identified by ACB score. Data analysis assesses cognitive functions, CAIDE risk factors, and high ACB medication use.

Flowchart of the study. CAIDE, Cardiovascular Risk Factors, Aging, and Incidence of Dementia (The CAIDE Dementia Risk Score), s-MoCA, short version of the Montreal Cognitive Assessment Screening Tool; ACB, Anticholinergic Burden Scale.